Related references
Note: Only part of the references are listed.Activity of β-lactam/taniborbactam (VNRX-5133) combinations against carbapenem-resistant Gram-negative bacteria
Shazad Mushtaq et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
Potent inhibitory activity of taniborbactam towards NDM-1 and NDM-1Q119X mutants, and in vitro activity of cefepime/taniborbactam against MBLs producing Enterobacterales
Alessandra Piccirilli et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2021)
An update on cefepime and its future role in combination with novel beta-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa
Burcu Isler et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
Activity of imipenem/relebactam against a Spanish nationwide collection of carbapenemase-producing Enterobacterales
Juan Carlos Vazquez-Ucha et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
Increasing frequency of OXA-48-producing Enterobacterales worldwide and activity of ceftazidime/avibactam, meropenem/vaborbactam and comparators against these isolates
Mariana Castanheira et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
AMRFinderPlus and the Reference Gene Catalog facilitate examination of the genomic links among antimicrobial resistance, stress response, and virulence
Michael Feldgarden et al.
SCIENTIFIC REPORTS (2021)
Third-generation cephalosporin resistance in clinical isolates of Enterobacterales collected between 2016-2018 from USA and Europe: genotypic analysis of β-lactamases and comparative in vitro activity of cefepime/enmetazobactam
Adam Belley et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2021)
In vitro efficacy of imipenem-relebactam and cefepime-AAI101 against a global collection of ESBL-positive and carbapenemase-producing Enterobacteriaceae
Lucas Tselepis et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections
Bin Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Impact of Intrinsic Resistance Mechanisms on Potency of QPX7728, a New Ultrabroad-Spectrum Beta-Lactamase Inhibitor of Serine and Metallo-Beta-Lactamases in Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii
Olga Lomovskaya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
In vitro activity of the novel β-lactamase inhibitor taniborbactam (VNRX-5133), in combination with cefepime or meropenem, against MDR Gram-negative bacterial isolates from China
Xiaojuan Wang et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Activity of cefepime/zidebactam against MDR Escherichia coli isolates harbouring a novel mechanism of resistance based on four-amino-acid inserts in PBP3
Sachin S. Bhagwat et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
In Vitro Activity of WCK 5222 (Cefepime-Zidebactam) against Worldwide Collected Gram-Negative Bacilli Not Susceptible to Carbapenems
James A. Karlowsky et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Microbiology of Meropenem-Vaborbactam: A Novel Carbapenem Beta-Lactamase Inhibitor Combination for Carbapenem-Resistant Enterobacterales Infections
Tanaya Bhowmick et al.
INFECTIOUS DISEASES AND THERAPY (2020)
Escherichia coli strains possessing a four amino acid YRIN insertion in PBP3 identified as part of the SIDERO-WT-2014 surveillance study
Takafumi Sato et al.
JAC-ANTIMICROBIAL RESISTANCE (2020)
Beyond Piperacillin-Tazobactam: Cefepime and AAI101 as a Potent β-Lactam - β-Lactamase Inhibitor Combination
Krisztina M. Papp-Wallace et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Host adaptation and convergent evolution increases antibiotic resistance without loss of virulence in a major human pathogen
Alicia Fajardo-Lubian et al.
PLOS PATHOGENS (2019)
In Vitro Activity of Cefepime-Enmetazobactam against Gram-Negative Isolates Collected from US and European Hospitals during 2014-2015
Ian Morrissey et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
β-Lactamases and β-Lactamase Inhibitors in the 21st Century
Catherine L. Tooke et al.
JOURNAL OF MOLECULAR BIOLOGY (2019)
Will morphing boron-based inhibitors beat the β-lactamases?
Alen Krajnc et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2019)
Identification of Mutations in the mrdA Gene Encoding PBP2 That Reduce Carbapenem and Diazabicyclooctane Susceptibility of Escherichia coli Clinical Isolates with Mutations in ftsI (PBP3) and Which Carry blaNDM-1
Srijan Ranjitkar et al.
MSPHERE (2019)
The latest advances in β-lactam/β-lactamase inhibitor combinations for the treatment of Gram-negative bacterial infections
Krisztina M. Papp-Wallace
EXPERT OPINION ON PHARMACOTHERAPY (2019)
Bicyclic Boronate VNRX-5133 Inhibits Metallo- and Serine-β-Lactamases
Alen Krajnc et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
VNRX-5133 (Taniborbactam), a Broad-Spectrum Inhibitor of Serine- and Metallo-β-Lactamases, Restores Activity of Cefepime in Enterobacterales and Pseudomonas aeruginosa
Jodie C. Hamrick et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
β-Lactamases: A Focus on Current Challenges
Robert A. Bonomo
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
High ceftazidime hydrolysis activity and porin OmpK35 deficiency contribute to the decreased susceptibility to ceftazidime/avibactam in KPC-producing Klebsiella pneumoniae
Zhen Shen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Unicycler: Resolving bacterial genome assemblies from short and long sequencing reads
Ryan R. Wick et al.
PLOS COMPUTATIONAL BIOLOGY (2017)
Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae
Olga Lomovskaya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
What Is the Appropriate Meropenem MIC for Screening of Carbapenemase-Producing Enterobacteriaceae in Low-Prevalence Settings?
Ramzi Fattouh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
β-Lactams and β-Lactamase Inhibitors: An Overview
Karen Bush et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
In Vivo Activities of Simulated Human Doses of Cefepime and Cefepime-AAI101 against Multidrug-Resistant Gram-Negative Enterobacteriaceae
Jared L. Crandon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Characterization of Escherichia coli NDM isolates with decreased susceptibility to aztreonam/avibactam: role of a novel insertion in PBP3
Richard A. Alm et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Prokka: rapid prokaryotic genome annotation
Torsten Seemann
BIOINFORMATICS (2014)
Mutations of the ompK36 Porin Gene and Promoter Impact Responses of Sequence Type 258, KPC-2-Producing Klebsiella pneumoniae Strains to Doripenem and Doripenem-Colistin
Cornelius J. Clancy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Identification of acquired antimicrobial resistance genes
Ea Zankari et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Diazabicyclooctanes (DBOs): a potent new class of non-β-lactam β-lactamase inhibitors
Ken Coleman
CURRENT OPINION IN MICROBIOLOGY (2011)
Share Paper
